Prospera Financial Services Inc boosted its position in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 3.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 23,304 shares of the company’s stock after purchasing an additional 883 shares during the quarter. Prospera Financial […]
Raymond James & Associates grew its stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,382,557 shares of the company’s stock after buying an additional 11,832 shares during the quarter. Raymond James […]
Raymond James & Associates increased its position in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 0.9% during the 4th quarter, HoldingsChannel reports. The fund owned 1,382,557 shares of the company’s stock after acquiring an additional 11,832 shares during the quarter. Raymond James & Associates’ holdings in Novo Nordisk A/S were worth $187,116,000 […]
Van ECK Associates Corp trimmed its stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 11.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 232,662 shares of the company’s stock after selling 30,027 shares during the quarter. Van ECK Associates Corp’s […]
Lincoln National Corp lifted its position in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 15.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,665 shares of the company’s stock after acquiring an additional 1,034 shares during […]